Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab and Triamcinolone in Acute NAION
NCT01330524Phase 2Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2010
- Primary completion
- Nov 2010
- Modality
- Monoclonal Antibodies, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab, triamcinolone in non-arteritic anterior ischemic optic neuropathy (NAION), sponsored by Shahid Beheshti University of Medical Sciences. Status: unknown.
02
Drugs
bevacizumabtriamcinolone
03
Conditions
non-arteritic anterior ischemic optic neuropathy (NAION)
Beyond the preview
Go deeper on NCT01330524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01330524.